Skip to main content
Clinical Trials/NCT05416502
NCT05416502UnknownNot Applicable

Prospective Observational Evaluation of the Relationship Between the Rates of Spontaneous Passage of Distal Ureteral Stones and the Diameter of the Most Narrow Part of the Distal Ureter

Hiram's Healthcare and Education Company1 site in 1 country1,000 target enrollmentStarted: January 1, 2021Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Sponsor
Enrollment
1,000
Locations
1
Primary Endpoint
Passage

Study Overview

Brief Summary

Patients (female, male, or queer) with ureteral stones (smaller than 1 cm at the widest diameter of the stone) without pyonephrosis, urinary sepsis, or untraceable pain will be enrolled into the study. Ureteral width at the smallest area of the ureter (in most cases UV junction) will be noted during regular ultrasound scans. The ratio of ureteral width to the stone diameter will be correlated with the spontaneous stone passage.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Ureteral Stone smaller than 1 cm Volunteer to be enrolled

Exclusion Criteria

  • Pyonephrosis Urinary Sepsis Untraceable Pain

Outcomes

Primary Outcomes

Passage

Time Frame: 3 months

The number of recruited individuals whose ureteral stones are found to be passed by their report and it is confirmed by ultrasound

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
Hiram's Healthcare and Education Company
Sponsor Class
Industry
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials

Prospective Relationship Between the Rates... | Clinical Trial